(19)
(11) EP 3 062 778 A1

(12)

(43) Date of publication:
07.09.2016 Bulletin 2016/36

(21) Application number: 14858628.2

(22) Date of filing: 29.10.2014
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/485(2006.01)
A61P 25/04(2006.01)
A61K 9/22(2006.01)
(86) International application number:
PCT/US2014/062887
(87) International publication number:
WO 2015/066172 (07.05.2015 Gazette 2015/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 31.10.2013 US 201361898207 P
17.07.2014 US 201414333986
17.07.2014 WO PCT/US2014/047014
04.09.2014 US 201414477354
04.09.2014 WO PCT/US2014/054061
12.09.2014 US 201414484793

(71) Applicant: Cima Labs Inc.
Brooklyn Park, Minnesota 55428 (US)

(72) Inventors:
  • HASWANI, Dinesh K.
    Plymouth, Minnesota 55446 (US)
  • MOE, Derek V.
    Mound, Minnesota 55364 (US)
  • O'NEILL, Victoria A.
    Wayzata, Minnesota 55391 (US)
  • VEGA ZEPEDA, Manuel A.
    Minnetonka, Minnesota 55345 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS